Carotid Endarterectomy and Stenting in a Chinese Population: Safety Outcome of the Revascularization of Extracranial Carotid Artery Stenosis Trial.


Journal

Translational stroke research
ISSN: 1868-601X
Titre abrégé: Transl Stroke Res
Pays: United States
ID NLM: 101517297

Informations de publication

Date de publication:
04 2021
Historique:
received: 07 05 2020
accepted: 07 07 2020
revised: 06 07 2020
pubmed: 21 7 2020
medline: 14 1 2022
entrez: 21 7 2020
Statut: ppublish

Résumé

Carotid endarterectomy (CEA) and carotid artery stenting (CAS) have been well-established as two effective treatment modalities for carotid artery stenosis, while their clinical outcomes in real-world China are still unknown due to lack of nationwide trials. We aimed to evaluate the safety outcome profile of CEA and CAS in Chinese patients with carotid artery stenosis. The Revascularization of Extracranial Carotid Artery Stenosis trial was a multicentre, prospective cohort study of CEA or CAS in treating patients with carotid artery stenosis. We included symptomatic or asymptomatic patients with carotid artery stenosis (≥ 50%). The primary endpoint was any stroke, myocardial infarction and/or death within 1 month post-procedure. Overall, 2719 cases (1543 CAS-treated patients and 1176 CEA-treated patients) were enrolled from 36 centres. The primary outcome was 4.3% (95% CI 3.2-5.6%) and 4.7% (95%CI 3.5-6.3%) in the symptomatic and asymptomatic patients, respectively. No significant difference in the primary outcome was found between CAS and CEA in both symptomatic (p = 0.338) and asymptomatic (p = 0.890) patients. High- versus low-volume centre significantly related to lower rate of primary outcome in CEA-treated patients (OR 2.54; 95%CI 1.19-5.44; p = 0.017) and asymptomatic patients (OR 2.54; 95%CI 1.42-4.54; p = 0.002). CEA and CAS decided by surgeons' discretion have comparable risks among patients with carotid artery stenosis in China. Both CEA and CAS should be avoided in asymptomatic patients until a consistently low complication rate is showed with centre-level audits. Medical treatment for patients with carotid stenosis in China needs to be improved. Trial registration: NCT01994187 ( ClinicalTrials.gov ).

Identifiants

pubmed: 32686047
doi: 10.1007/s12975-020-00835-8
pii: 10.1007/s12975-020-00835-8
doi:

Banques de données

ClinicalTrials.gov
['NCT01994187']

Types de publication

Clinical Trial Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

239-247

Subventions

Organisme : the National Science and Technology Support Program
ID : 2011BAI08B04
Organisme : the National Key Research and Development Project
ID : 2016YFC1301703
Organisme : the Beijing Scientific and Technologic Project
ID : D161100003816002

Références

Mehndiratta MM, Khan M, Mehndiratta P, Wasay M. Stroke in Asia: geographical variations and temporal trends. J Neurol Neurosurg Psychiatry. 2014;85(12):1308–12.
doi: 10.1136/jnnp-2013-306992
Guan T, Ma J, Li M, Xue T, Lan Z, Guo J, et al. Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013. Neurology. 2017;89(1):53–61.
doi: 10.1212/WNL.0000000000004056
Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke. 1999;30(12):2513–6.
doi: 10.1161/01.STR.30.12.2513
Wang X, Li W, Song F, et al. Carotid atherosclerosis detected by ultrasonography: a national cross-sectional study. J Am Heart Assoc. 2018;7(8):e008701.
Mo D, Wang B, Ma N, Gao F, Miao Z. Comparative outcomes of carotid artery stenting for asymptomatic and symptomatic carotid artery stenosis: a single-center prospective study. J Neurointerv Surg. 2016;8(2):126–9.
doi: 10.1136/neurintsurg-2014-011437
Yang L, Liu J, Qi G, Li Y, Liu Y. The middle-term outcome of carotid endarterectomy and stenting for treatment of ischemic stroke in Chinese patients. Sci Rep. 2018;8(1):4697.
doi: 10.1038/s41598-018-23061-7
Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. Catheter Cardiovasc Interv. 2013;81(1):E76–123.
Kozak LJ, Lees KA, De Frances CJ. National Hospital Discharge Survey: 2003 Annual summary with detailed diagnosis and procedure data. Vital Health Stat Series 13, Data from the National Health Survey. 2006(160):1–206.
Barnett HJM, Taylor DW, Haynes RB, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325(7):445–53.
doi: 10.1056/NEJM199108153250701
Chen Z, Yang YG. Guideline for diagnosis and management of carotid artery stenosis. Chin J Vasc Surg. 2017;9(03):169–75. http://med.wanfangdata.com.cn/Paper/Detail?id=PeriodicalPaper_zgxgwkzz201703003&dbid=WF_QK
Ca RSC. Carotid revascularization using Endarterectomy or stenting systems (CaRESS) phase I clinical trial: 1-year results. J Vasc Surg. 2005;42(2):213–9.
doi: 10.1016/j.jvs.2005.04.023
Brott TG, Hobson RW 2nd, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.
doi: 10.1056/NEJMoa0912321
Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(2):517–84.
doi: 10.1161/STR.0b013e3181fcb238
Kuehnl A, Tsantilas P, Knappich C, et al. Significant association of annual hospital volume with the risk of inhospital stroke or death following carotid endarterectomy but likely not after carotid stenting: secondary data analysis of the statutory German carotid quality assurance database. Circ Cardiovasc Interv. 2016;9(11):e004171.
Zhou DB. Treatment of transient ischemic attack by carotid endarterectomy. Zhonghua wai ke za zhi [Chinese journal of surgery]. 1989;27(12):743–5 781.
Liu X, Xu G. Endovascular treatments of atherosclerotic carotid diseases in China. Int J Stroke. 2010;5(5):417–20.
doi: 10.1111/j.1747-4949.2010.00471.x
Song G, et al. The management of carotid endarterectomy in China: current situation and literature review. Chin J Cerebrovasc Dis. 2014;11(1):1–5.
Song G, et al. The management of carotid artery stenting in China: current situation and literature review. Chin J Cerebrovasc Dis. 2014;11(3):113–7.

Auteurs

Bin Yang (B)

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.

Yan Ma (Y)

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.

Tao Wang (T)

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.

Yanfei Chen (Y)

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.

Yinzhou Wang (Y)

Department of Neurology, Fujian Provincial Hospital, Fuzhou, Fujian, China.

Zhenwei Zhao (Z)

Department of Neurosurgery, Tangdu Hospital, Xian, Shanxi, China.

Dong Chen (D)

Department of Neurosurgery, Dalian Municipal Central Hospital, Dalian, Liaoning, China.

Jiyue Wang (J)

Department of Neurosurgery, Liaocheng Brain Hospital, Liaocheng, Shandong, China.

Xiaolin Xu (X)

Department of Neurology, Huanhu Hospital, Tianjin, China.

Tao Luo (T)

Department of Vascular Surgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

Yang Hua (Y)

Department of Vascular Ultrasonography, Xuanwu Hospital, Capital Medical University, Beijing, China.

Feng Ling (F)

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China.

Adnan I Qureshi (AI)

Zeenet Qureshi Stroke Institute, St Cloud, MN and Department of Neurology, University of Missouri, Columbia, MO, USA.

Bo Hong (B)

Department of Neurosurgery, Changhai Hospital, No. 168, Changhai Road, Shanghai, China. hongbosmmu@vip.126.com.

Liqun Jiao (L)

Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, No. 45, Changchun Street, Beijing, China. liqunjiao@sina.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH